GlucoSet is medical device company that is developing sensor technology for improved glucose control in intensive care units.
GlucoSet is medical device company that is developing sensor technology for improved glucose control in intensive care units.Blood glucose levels are elevated and unstable in hospital intensive care unit (ICU) patients. This leads to costly infections, increased length of stay and mortality. The GlucoSet intravascular sensor delivers continuous and accurate information on patient's blood glucose level, enabling normalization of glucose levels, without the risk of sudden and dangerously low glucose levels.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 11, 2018 | Angel | €60K | 1 | Nordic Angel Program | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Nordic Angel Program | Yes | Angel |